Bayer, J & J's bid to further widen use of Xarelto hits snag

Bayer and Johnson& Johnson's campaign to widen the patient group for their heart drug Xarelto hit a snag when two smaller studies failed to show a statistically reliant benefit.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news